Whiteboard video on using the Acetylcholinesterase/memantine deprescribing algorithm

Appropriate use of cholinesterase inhibitors and memantine involves both prescribing these medications to individuals who are likely to benefit, and deprescribing (withdrawing) them for individuals where the risks outweigh the benefits. People with dementia and their families should always discuss plans to reduce or stop medications with their doctors and pharmacists.